首页 > 市场调查报告书 > 医疗设备

居家医疗

市场调查报告书

商品编码

1588548

全球家庭医疗保健产业市场 - 2024-2031

Global Home Healthcare Industry Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 201 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年全球家庭医疗保健产业市场规模达2,695.3亿美元，预估至2031年将达4,742.5亿美元，2024-2031年预测期间复合年增长率为7.32%。

由于人口老化和慢性病盛行率上升，对家庭护理服务的需求不断增长，全球家庭医疗保健行业市场正在迅速扩张。家庭医疗保健包括护理、物理治疗、远距医疗和辅助设备等各种服务。这种护理模式为患者提供了在家中接受医疗的便利，从而降低了住院的必要性并减少了医疗费用。

远距医疗和远距患者监护的广泛采用进一步推动了该行业的成长，这些技术已成为管理糖尿病、心臟病和呼吸系统疾病等慢性病患者的重要工具。美国医疗保险和医疗补助服务中心 (CMS) 和世界卫生组织 (WHO) 制定的监管框架在标准化家庭医疗保健服务的品质和安全方面发挥了至关重要的作用。

由于老年人口的增加、技术的采用以及政府为减少医院拥挤而做出的努力，亚太地区正在成为家庭医疗保健成长最快的市场之一。在政府促进居家养老的政策的支持下，日本、中国和印度等国家对家庭医疗保健服务的需求正在激增。日本是世界上人口老化最快的国家之一，在家庭医疗保健技术方面进行了大量投资。

动力学

技术进步和人口老化

科技创新加上全球人口老化是家庭医疗保健市场的关键驱动力。智慧显示器、远距医疗平台和穿戴式装置等先进的医疗保健设备正在成为家庭医疗保健不可或缺的一部分。这些技术有助于慢性病的管理、减少去医院次数并提高病患照护的整体效率。例如，穿戴式心臟监测器可以为医疗保健提供者提供即时更新，以便在必要时进行及时干预。

老年人口的增加是另一个主要驱动力。根据联合国 (UN) 预测，2019 年至 2050 年间，全球 80 岁及以上人口数量预计将增加两倍，从 1.43 亿增至 4.26 亿。这一特定人群的增加导致对家庭医疗保健服务的需求更大，因为老年人选择在自己的家中接受护理，而不是长期住在医院并承担高额医疗费用。

不断上涨的医疗成本和政府支持

医疗保健费用的不断增加促使患者和医疗保健提供者寻求经济的选择，与医院治疗相比，家庭医疗保健可以节省大量成本。根据医疗保险和医疗补助服务中心 (CMS) 的说法，家庭医疗保健是管理慢性病和手术復健的经济有效的选择，因为它比医院护理便宜得多。由于预算限制，医疗保健系统正在以报销政策和税收优惠的形式获得更多政府援助，以促进家庭医疗保健服务的使用。

此外，美国劳工统计局预测，从 2020 年到 2030 年，家庭医疗保健产业的就业机会将增加 29%，超过所有职业的平均成长率，突显该产业在医疗保健服务中的重要性日益增强。此外，此类政府努力对于推动市场向前发展至关重要，因为全球家庭医疗保健支出预计每年都会以显着的速度成长。这种成长在人口老化和医院系统不堪重负的国家尤其明显。

劳动力短缺和监管挑战

劳动力短缺和监管障碍是阻碍家庭医疗保健产业成长的关键因素。包括护士和助手在内的合格家庭保健人员的短缺给服务提供压力，特别是在农村地区。世卫组织预计，到 2030 年，要加快全民健康覆盖，将短缺 1,800 万名卫生工作者，特别是在低收入和中低收入国家，这将加剧家庭医疗保健问题。

此外，监管挑战也限制了市场成长。拥有严格医疗保健法规的国家可能在报销流程、家庭医疗保健提供者的认证要求以及围绕使用数位健康监测工具的隐私问题方面面临障碍。这些监管瓶颈往往会减缓家庭医疗保健新技术和服务的采用。

The global home healthcare industry market is expanding rapidly due to the rising demand for in-home care services driven by an aging population and an increased prevalence of chronic diseases. Home healthcare includes a variety of services such as nursing care, physical therapy, telehealth and assistive devices. This care model provides patients with the convenience of receiving medical care at home, which in turn lowers the necessity for hospitalization and reduces healthcare expenses.

The industry's growth is further propelled by the widespread adoption of telemedicine and remote patient monitoring, which have become essential tools for managing patients with chronic conditions like diabetes, heart disease and respiratory disorders. Regulatory frameworks, such as those set by US Centers for Medicare & Medicaid Services (CMS) and the World Health Organization (WHO), have played a crucial role in standardizing quality and safety in-home healthcare services.

Asia-Pacific is becoming one of the fastest growing markets for home healthcare due to the increasing elderly population, adoption of technology and government efforts to decrease hospital congestion. Countries such as Japan, China and India are witnessing a surge in demand for home healthcare services, supported by government policies promoting elderly care at home. Japan, with one of the world's most rapidly aging populations, has seen significant investment in home healthcare technologies.

Dynamics

Technological Advancements and Aging Population

Technological innovations, coupled with the aging global population, are key drivers in the home healthcare market. Advanced healthcare devices such as smart monitors, telehealth platforms and wearable devices are becoming integral to in-home medical care. These technologies aid in the management of chronic conditions, lessen hospital trips and enhance overall efficiency in patient care. For instance, wearable heart monitors can offer healthcare providers instant updates, allowing for prompt interventions as necessary.

The increasing elderly population is another major driver. According to the United Nations (UN), the global number of people aged 80 years or older is expected to triple between 2019 and 2050, increasing from 143 million to 426 million. The increase in this specific demographic leads to a greater need for home healthcare services, as elderly people opt to be cared for in their own homes instead of staying in hospitals for long periods and incurring high healthcare expenses.

Rising Healthcare Costs and Government Support

The increasing expense of healthcare is driving patients and healthcare providers to seek economical options, with home healthcare providing substantial cost savings in comparison to hospital treatment. According to the Centers for Medicare & Medicaid Services (CMS), home healthcare is a cost-effective option for managing chronic diseases and recovering from surgeries, as it is notably cheaper than hospital care. With budget limitations, healthcare systems are gaining more government aid in the form of reimbursement policies and tax incentives to promote the use of home healthcare services.

Furthermore, US Bureau of Labor Statistics predicts a 29% increase in job opportunities within the home healthcare industry from 2020 to 2030, surpassing the average growth rate for all professions and highlighting the sector's increasing significance in healthcare services. Additionally, government efforts like these are essential for driving the market forward, as global healthcare expenditures on home healthcare are expected to increase with a notable growth rate each year. This increase is particularly noticeable in nations with elderly populations and overwhelmed hospital systems.

Workforce Shortages and Regulatory Challenges

Workforce shortages and regulatory hurdles are the key factors that hamper the growth of the home healthcare industry. A shortage of qualified home healthcare workers, including nurses and aides, is placing a strain on service delivery, especially in rural areas. WHO projects a shortfall of 18 million health workers to accelerate universal health coverage by 2030, particularly in low- and lower-middle-income countries, exacerbating the issue of home healthcare.

Additionally, regulatory challenges pose a restraint on market growth. Countries with stringent healthcare regulations may face barriers in terms of reimbursement processes, certification requirements for home healthcare providers and privacy concerns surrounding the use of digital health monitoring tools. These regulatory bottlenecks often slow down the adoption of new technologies and services in home healthcare.

Segment Analysis

The global home healthcare industry market is segmented based on offering, indication and region.

Demand for Assistive Devices and Remote Monitoring Tools

The demand for home healthcare market is driven by the adoption of assistive devices and remote monitoring tools. The devices help manage chronic diseases and enable elderly or disabled individuals to live more independently. According to the United Nations, the global population aged 60 years or over is expected to double by 2050, driving increased demand for devices like mobility aids, oxygen delivery systems and home dialysis equipment.

Telehealth and remote patient monitoring are also experiencing significant demand as they enable healthcare providers to monitor patient's conditions without the need for in-person visits. Furthermore, advancements in communication technologies and the increasing prevalence of chronic conditions such as diabetes and hypertension also drive the home health market growth. Moreover, these tools reduce the burden on healthcare systems by allowing for continuous monitoring and early intervention, which can help prevent hospital readmissions and improve overall patient outcomes.

Geographical Penetration

Demand for Home-Based Medical Services in North America

North America dominates the global home healthcare market, driven by a strong demand for home-based medical services, particularly for managing chronic diseases like cardiovascular disease (CVD) and cancer. According to the Centers for Disease Control and Prevention (CDC), heart disease accounted for 680,909 deaths in US in 2023, making it the third leading cause of death. With cancer (613,331 deaths) and unintentional injuries (222,518 deaths) also among the top causes, the need for at-home healthcare solutions for chronic disease management has intensified.

US healthcare system is increasingly adopting home healthcare solutions as a cost-effective alternative to hospital-based care. As healthcare costs continue to rise, patients are seeking home-based treatment options for post-surgery recovery and chronic disease management. US government's support, through reimbursement policies and tax incentives, further drives the adoption of home healthcare technologies and services.

Competitive Landscape

The major global players in the market include Omron Healthcare, Inc, 3M, Air Liquide, B. Braun Melsungen AG, Linde plc, GE HealthCare, Koninklijke Philips N.V., Dickinson and Company, A&D Company Limited and Addus HomeCare Corporation.

Sustainability Analysis

Sustainability is becoming an increasingly important factor in the global home healthcare industry, with a growing emphasis on reducing the environmental impact of medical waste and energy consumption. The adoption of energy-efficient medical equipment and telehealth tools is reducing the healthcare sector's carbon footprint, as digital healthcare technologies are decreasing the reliance on physical infrastructure.

According to the Global Sustainability Council for Healthcare (GSCH), the home healthcare market can contribute significantly to global sustainability goals by reducing the need for hospital infrastructure, thereby decreasing energy consumption and waste generation. Specifically, remote patient monitoring systems and telemedicine help decrease the need for patients to travel and be admitted to the hospital, supporting a more sustainable healthcare system. Furthermore, companies are increasingly focused on designing recyclable and biodegradable medical devices, aligning with global environmental regulations and consumer demand for eco-friendly solutions.

Russia-Ukraine War Impact

The ongoing Russia-Ukraine war has created both direct and indirect challenges for the global home healthcare industry. One of the main impacts has been the disruption of medical device and healthcare supply chains across Europe. Ukraine is an essential provider of electronic parts for medical equipment, including those for home medical care. The conflict has caused disruptions in the supply chain, resulting in shortages and higher prices for medical devices, which has in turn delayed the adoption of home healthcare technologies.

Moreover, with the geopolitical situation resulting in a significant humanitarian crisis, healthcare systems in neighboring countries have been overwhelmed by the influx of refugees. This situation has redirected healthcare resources, including home healthcare services, to crisis management. Furthermore, governments in impacted areas are increasing financial allocation to military expenses, possibly leading to a decrease in funding for healthcare, such as home healthcare initiatives.

By Offering

Services
- Physician primary care
- Nursing care
- Physical/occupational/speech therapy
- Nutritional support
- Unskilled Care
- Others
Products
- Therapeutic Products
- Testing, Screening and Monitoring Products
- Mobility Care Products
- Others

By Indication

Cancer
Neurological Disorders
Mobility Disorders
Diabetes
Cardiovascular Disorders
Others

Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In June 2023, Amedisys, a leading provider of personalized home health and hospice care, announced its agreement to combine with Optum, a diversified health services company. Amedisys provides specialized care to patients in their homes through over 11.2 million home visits each year. This merger is intended to improve the provision of complete home healthcare services, leading to better patient results and increasing their presence in the expanding home healthcare industry.
In February 2023, 3M launched a new medical adhesive designed for use with a variety of sensors, health monitors and long-term medical wearables. This strategic move helped 3M broaden its product offering in the home healthcare space, particularly in medical wearables, by catering to the growing demand for remote patient monitoring solutions.
In November 2022, the Pennant Group, Inc. acquired a Wisconsin-based home health provider to deliver skilled home health and community health services in Kenosha, Wisconsin. This acquisition reflects Pennant's strategy to strengthen its footprint in the home healthcare market.

Why Purchase the Report?

To visualize the global home healthcare industry market segmentation based on offering, indication and region.
Identify commercial opportunities by analyzing trends and co-development.
Excel spreadsheet containing a comprehensive dataset of the home healthcare industry market, covering all levels of segmentation.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global home healthcare industry market report would provide approximately 46 tables, 35 figures and 201 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Offering
3.2. Snippet by Indication
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements and Aging Population
  - 4.1.1.2. Rising Healthcare Costs and Government Support
- 4.1.2. Restraints
  - 4.1.2.1. Workforce Shortages and Regulatory Challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. By Offering

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 6.1.2. Market Attractiveness Index, By Offering
6.2. Services*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 6.2.2.1. Physician primary care
  - 6.2.2.2. Nursing care
  - 6.2.2.3. Physical/occupational/speech therapy
  - 6.2.2.4. Nutritional support
  - 6.2.2.5. Unskilled Care
  - 6.2.2.6. Others
6.3. Products
- 6.3.1. Introduction
- 6.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 6.3.2.1. Therapeutic Products
  - 6.3.2.2. Testing, Screening and Monitoring Products
  - 6.3.2.3. Mobility Care Products
  - 6.3.2.4. Others

7. By Indication

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 7.1.2. Market Attractiveness Index, By Indication
7.2. Cancer*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Neurological Disorders
7.4. Mobility Disorders
7.5. Diabetes
7.6. Cardiovascular Disorders
7.7. Others

8. Sustainability Analysis

8.1. Environmental Analysis
8.2. Economic Analysis
8.3. Governance Analysis

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. US
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Offering
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Omron Healthcare, Inc*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. 3M
11.3. Air Liquide
11.4. B. Braun Melsungen AG
11.5. Linde plc
11.6. GE HealthCare
11.7. Koninklijke Philips N.V.,
11.8. Dickinson and Company
11.9. A&D Company Limited
11.10. Addus HomeCare Corporation.

LIST NOT EXHAUSTIVE